A second opinion before the marketing plan is locked.
Pharmaceutical digital strategy consulting for marketing teams who want an outside, evidence-based read on the plan before committing budget: what channels are worth the investment, what is likely to underperform given the category’s real constraints, and what is missing.
Internal marketing plans are shaped by internal politics, prior investment and what worked at a different company in a different category. An outside review, grounded specifically in what pharmaceutical marketing can and cannot do, catches assumptions that would otherwise survive unchallenged into the budget.
A structured review of the current or proposed plan, channel-by-channel assessment against realistic constraints, gap identification, and a set of concrete recommendations you can act on with or without us.
We do not rubber-stamp a plan to win a larger implementation contract afterward — the review stays honest even when the honest answer is less activity, not more, and even when that means recommending against work we could otherwise be paid to do.
The scope our pharmaceutical digital strategy consulting work has covered.
The trigger varies. Pharmaceutical digital strategy consulting starts from what prompted the question.
What comes up before commissioning an outside review.
No, the review is independent of whether you go on to implement it with us. It is common for the honest recommendation to include doing less in certain channels rather than more everywhere, and we would rather tell you that than pad a plan to justify a bigger engagement.
Yes, and reviewing a plan already built elsewhere is one of the more common reasons this engagement gets commissioned in the first place. Companies want a second, independent read on a strategy before committing further budget to it, and we assess it on its merits regardless of who wrote it.
Timeline scales with the complexity of the plan and the number of markets it covers. A single-market laboratory strategy is reviewed considerably faster than a multi-affiliate, multi-market plan involving several stakeholder groups, and we give a realistic estimate once we have seen the scope of what needs reviewing.
Related but distinct: digital product strategy covers which platforms and products to build, while this engagement covers the marketing plan and channel strategy around them. Many companies commission both in sequence, since the product decisions and the marketing plan need to line up with each other.
Strategy consulting usually leads into specific channel work. These are the services the recommendations often point toward.
A plan about to be committed, or one already running that has not been questioned in a while. Tell us what you have and we will tell you how we would approach the pharmaceutical digital strategy consulting.